Labcorp Raises 2026 Guidance as Q3 Earnings and Revenue Rise

Healthcare diagnostics company Labcorp Holdings NYSE:LHreported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 6.9% year on year to $3.81 billion. The company’s full-year revenue guidance of $14.83 billion at the midpoint came in 0.6% above analysts’ consensus estimates…

Labcorp Raises 2026 Adjusted EPS Guidance to $18.30-$18.70 Labcorp raised its 2026 adjusted EPS

Labcorp reported third-quarter 2026 revenue of $3.81 billion, exceeding the FactSet estimate of $3.76 billion, and adjusted earnings per share (EPS) of $4.78, which surpassed the estimate of $4.64. The company achieved 7% year-over-year revenue growth and a 14.5% increase in adjusted EPS, driven by margin expansion and operating leverage. Following these results, Labcorp raised its full-year 2026 guidance, now expecting an adjusted EPS range of $18.30 to $18.70 and a revenue range of $14.78 billion to $14.89 billion. Additionally, the company reported $255.5 million in acquisitions during the quarter and declared a quarterly dividend of $0.72 per share.